|Home||» Products||» Daclatasvir Medicines||» MyDacla Tablets|
Mydacla 60 Daclatasvir Dihydrochloride Tablets
MyDacla is prescribed by the medical professionals with sofobusvir as the treatment of the patients suffering with chronic Heptitis Virus genotype 3. Patients receiving this medication have reported sustained virologic response rate reduction of HCV genotype 3. The treatment done by this medicine must be monitored by physician who is proficient in the treatment of chronic hepatitis C. Its generic name is Daclatasvir Dihydrochloride and is manufactured by Mylan.
How does Daclatasvir work?
Daclatasvir is a new antiviral direct acting drug which targets several stages of the life cycle of hepatitis C virus or HCV. It is the first HCV NS5A reproduction inhibitor which is given approval. It interferes with protein which the virus uses to replicate.
Who can use daclatasvir?
This drug is safe to be taken by the people above 18 years in age suffering with Hepatitis C lasting for more than 6 months. It is prescribed to the patients suffering with genotype 1, 2, 3 or 4. It can be taken by the patients of Hepatitis C for the first time and also by the patients who have not benefited by previous interferon treatment.
It has several mild to moderate side effects like nausea, vomiting, fatigue, rashes, headache, etc. associated with its usage. Patients must contact the doctor if they experience any of these.
This drug must be taken by the patients only in the supervision of the doctor as this may cause several side effects.